Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04464759
Title A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma (LIMIT)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ravi Amaravadi, MD




Hydroxychloroquine + Ipilimumab + Nivolumab

Hydroxychloroquine + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Abramson Cancer Center at University of Pennsylvania Recruiting Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from for the field